SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis. (2017)
Attributed to:
Nottingham Molecular Pathology Node (NMPN) for Integrated Multi-platform Biomarker Research and Knowledge Transfer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.15252/emmm.201707860
PubMed Identifier: 29109128
Publication URI: http://europepmc.org/abstract/MED/29109128
Type: Journal Article/Review
Volume: 9
Parent Publication: EMBO molecular medicine
Issue: 12
ISSN: 1757-4676